Here’s How Much You Would Have Made Owning Sterling Infrastructure Stock In The Last 15 Years
Sterling Infrastructure (NASDAQ:STRL) has outperformed the market over the past 15 years by 2.08% on an annualized basis…
12 Industrials Stocks Moving In Monday’s Pre-Market Session
Gainers New Horizon Aircraft (NASDAQ:HOVR) shares rose 111.1% to $1.52 during Monday’s pre-market session. The market value of…
(STRL) – Analyzing Sterling Infrastructure’s Short Interest
Sterling Infrastructure’s (NYSE:STRL) short percent of float has risen 3.76% since its last report. The company recently reported…
Jim Cramer Says Nu Skin Is ‘Overvalued,’ Praises ‘Fabulous’ Pure Storage
Jim Cramer, when asked about Albemarle, said "Anything connected with [electric vehicles] right now is a no go."
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Shares of Beyond, Inc. (NYSE:BYON) fell sharply during Tuesday’s session following weaker-than-expected quarterly results. Beyond posted adjusted loss of…
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones gaining over 80 points on Tuesday. Shares of Tempur Sealy…
10 Industrials Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…
12 Industrials Stocks Moving In Tuesday’s Intraday Session
Gainers Ocean Power Techs (AMEX:OPTT) shares increased by 23.2% to $0.34 during Tuesday’s regular session. The market value…
11 Industrials Stocks Moving In Friday’s After-Market Session
Gainers C3is (NASDAQ:CISS) stock increased by 4.7% to $0.48 during Friday’s after-market session. The company’s market cap stands…
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Gainers
PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.